The lungs cannot properly oxygenate the blood or clear carbon dioxide.
Acute respiratory failure is a serious, life-threatening medical condition in which the lungs suddenly fail to provide enough oxygen to the blood and tissues or to remove enough carbon dioxide from the blood (hypercapnia), or both.
One of the most common conditions encountered in ICU care.
It can develop rapidly—over hours to days—and is considered a medical emergency.
It requires emergency medical care.
Common causes include severe infections like sepsis, pneumonia, trauma, or drug overdose, which prevent the vital exchange of gases.
ARF develops rapidly, usually within hours or days.
ARF key indicators:Severe shortness of breath, blue tint to the lips, skin, or fingernails, mental confusion, extreme drowsiness, or dizziness, tachypnea, or using chest and neck muscles to breathe, anxiety or panic.
Symptoms Symptoms develop quickly and depend on severity and cause.
They may include: Shortness of breath (dyspnea), often severe and worsening with activity. Rapid, labored breathing (tachypnea). Bluish tint to the lips, face, or nails (cyanosis). Fatigue, anxiety, confusion, or agitation (especially from high CO₂). Fast heart rate, sweating, coughing, or chest discomfort. In severe cases: Loss of consciousness or irregular heartbeat.
ARF is triggered by an underlying disease, injury, or substance that affects the respiratory system.
Major causes include:Lung infections & diseases: Pneumonia, acute respiratory distress syndrome (ARDS), or severe COPD flare-ups.
Trauma: Chest injuries, collapsed lung, smoke inhalation, or drowning.
Neurological issues: Opioid overdoses, spinal cord injuries, or strokes that slow down the brain’s control over breathing.
Heart issues: Heart failure can cause fluid to build up in the lungs as pulmonary edema.
Diagnosis of ARF in an emergency setting using tools like:Arterial blood gas (ABG) test: Measures oxygen and carbon dioxide levels in the blood. Pulse oximetry: Provides an immediate, non-invasive reading of blood oxygen levels.
Chest X-ray or CT scan: Visualizes fluid build-up or structural damage in the lungs.
Risk factors include older age, smoking, obesity, alcohol or drug use, and pre-existing lung or heart conditions.
ARDS is frequently caused by sepsis or severe pneumonia and is more common in hospitalized critically ill patients.
Types of acute respiratory failure:
Type 1 (hypoxemic): Low oxygen levels in the blood (PaO₂ < 60 mmHg) without high carbon dioxide.
Often linked to lung problems like pneumonia or fluid buildup.
Type 2 (hypercapnic): High carbon dioxide levels (PaCO₂ > 45 mmHg) with low oxygen.
Often from conditions that make it hard to breathe deeply, such as COPD exacerbation or neuromuscular issues.
It can also be called acute hypoxemic respiratory failure (AHRF).
A related but more specific severe form is acute respiratory distress syndrome (ARDS), which involves widespread lung inflammation and fluid-filled air sacs (alveoli), severely impairing gas exchange.
ARDS often follows critical illness or injury.
Treatment:Treatment generally takes place in an Intensive Care Unit (ICU) and focuses on the underlying cause while supporting breathing.
Oxygen therapy: Delivering supplemental oxygen through a mask or nasal cannula.
Ventilator support: Using mechanical ventilation or CPAP/BiPAP machines to help the patient breathe.
Medications: Administering antibiotics for infections, bronchodilators to open airways, or diuretics to clear fluid from the lungs.
Diagnosis
Medical history and physical exam. Pulse oximetry and arterial blood gas (ABG) test (precise oxygen and CO₂ levels). Chest X-ray or CT scan to look for lung issues like fluid or collapse. Heart tests (e.g., EKG or echocardiogram) if cardiac causes are suspected.
Treatment Acute respiratory failure requires immediate hospital care, often in an intensive care unit (ICU).
Treatment focuses on supporting breathing while addressing the cause:
Oxygen therapy: Via nasal cannula, mask, high-flow nasal cannula, or non-invasive ventilation (e.g., CPAP/BiPAP) to improve oxygen levels.
Hi-flow nasal oxygen has been shown to improve survival in initial studies but subsequent studies have shown that the 28 day mortality rate was no different than that with the use of standard oxygen therapy in acute hypoxemic respiratory failure.
Mechanical ventilation: takes over breathing if needed.
Medications: For underlying issues-antibiotics for infection, diuretics for fluid overload or to reduce symptoms.
Other: Tracheostomy in some cases, IV fluids, and pulmonary rehabilitation for recovery.
In ARDS, specific supportive care (e.g., lung-protective ventilation) is critical, and extracorporeal membrane oxygenation (ECMO) may be used in refractory cases.
Outcomes vary widely based on the cause, age, overall health, and how quickly treatment starts.
Many people recover fully with prompt care, but mortality can be high—up to 1 in 3 hospitalized patients may not survive, especially with ARDS (30–40% in some cases) or older age.
Survivors may face lingering fatigue, breathing issues, or muscle weakness.
Early intervention greatly improves chances.
Among critically ill patient with acute respiratory failure neither carbocistine nor nebulized hypertonic saline significantly reduced the duration of mechanical ventilation and each was associated with harm (MARCH trial investigators).